Eagle Pharmaceuticals, Inc. Other Assets, Fair Value Disclosure
Eagle Pharmaceuticals, Inc. had Other Assets, Fair Value Disclosure of $8.13 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:OtherAssetsFairValueDisclosure · last filed 2023-08-09
- 2023-06-30: Other Assets, Fair Value Disclosure $8.13M.
- 2023-03-31: Other Assets, Fair Value Disclosure $8.13M.
- 2022-12-31: Other Assets, Fair Value Disclosure $8.13M.
- 2022-09-30: Other Assets, Fair Value Disclosure $8.13M.
| Period end | Other Assets, Fair Value Disclosure |
|---|---|
| 2023-06-30 | $8.13M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $8.13M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $8.13M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $8.13M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.80M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.50M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $6.03M 10-Q · filed 2022-08-09 |
| 2021-09-30 | $10.30M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $12.60M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $17.80M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $12.20M 10-K · filed 2022-03-08 |
| 2020-09-30 | $9.80M 10-Q · filed 2020-11-02 |